Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile
Steliana Huhulescu(Austrian Agency for Health and Food Safety), Alexander Indra(Austrian Agency for Health and Food Safety), Ulrich Sagel(Austrian Agency for Health and Food Safety), Franz Allerberger(University of Vienna), A. Fiedler(Austrian Agency for Health and Food Safety), Guenther Wewalka(Austrian Agency for Health and Food Safety), Marion Blaschitz(Austrian Agency for Health and Food Safety), Verena Pecavar(Austrian Agency for Health and Food Safety)
Cited by 31
Related Papers
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage
|Nature Communications|2019|1.2k
Listeriosis: a resurgent foodborne infection
|Clinical Microbiology and Infection|2009|685
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
|Clinical Microbiology and Infection|2021|615
Clinical Course and the Role of Shiga Toxin–Producing<i>Escherichia coli</i>Infection in the Hemolytic‐Uremic Syndrome in Pediatric Patients, 1997–2000, in Germany and Austria: A Prospective Study
|The Journal of Infectious Diseases|2002|365
Defining and Evaluating a Core Genome Multilocus Sequence Typing Scheme for Whole-Genome Sequence-Based Typing of Listeria monocytogenes
|Journal of Clinical Microbiology|2015|308